| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Chris T. Evelo | Q19845641 |
| P2093 | author name string | Finot E | |
| Dubernet C | |||
| Garrido C | |||
| Markey L | |||
| Nuyten DS | |||
| Seigneuric R | |||
| P2860 | cites work | Oncogenes and Cancer | Q22248112 |
| Understanding biophysicochemical interactions at the nano-bio interface | Q23909863 | ||
| Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control | Q24304179 | ||
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| Molecular engineering: An approach to the development of general capabilities for molecular manipulation | Q24620162 | ||
| Seeding and propagation of untransformed mouse mammary cells in the lung | Q24648060 | ||
| EpCAM (CD326) finding its role in cancer | Q24653692 | ||
| Nanoparticles: pharmacological and toxicological significance | Q24681563 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| The biology of the 17-1A antigen (Ep-CAM) | Q28140874 | ||
| A reactive poly(ethylene glycol) layer to achieve specific surface plasmon resonance sensing with a high S/N ratio: the substantial role of a short underbrushed PEG layer in minimizing nonspecific adsorption | Q28174463 | ||
| Integration from proteins to organs: the Physiome Project | Q28213276 | ||
| Clinical proteomics: Written in blood | Q28213537 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Cancer genes and the pathways they control | Q28275089 | ||
| Circulating mutant DNA to assess tumor dynamics | Q28289337 | ||
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| Nanotechnologies for biomolecular detection and medical diagnostics | Q28292243 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Tissue cells feel and respond to the stiffness of their substrate | Q29547613 | ||
| A molecular signature of metastasis in primary solid tumors | Q29614442 | ||
| Detection of mutations in EGFR in circulating lung-cancer cells | Q29615033 | ||
| Taking cell-matrix adhesions to the third dimension | Q29615214 | ||
| Cancer nanotechnology: opportunities and challenges | Q29615481 | ||
| Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Systemic spread is an early step in breast cancer | Q29617041 | ||
| The origins and the future of microfluidics | Q29617319 | ||
| Breast cancer metastasis: markers and models | Q29618061 | ||
| Drug delivery systems: entering the mainstream | Q29618136 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer | Q30080026 | ||
| Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases | Q30489779 | ||
| Bioassay of prostate-specific antigen (PSA) using microcantilevers. | Q30708669 | ||
| A rare-cell detector for cancer | Q31092483 | ||
| Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker | Q33283446 | ||
| Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma | Q33323321 | ||
| A progression puzzle | Q33337505 | ||
| Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data | Q33408667 | ||
| SERS-based plasmonic nanobiosensing in single living cells | Q33616919 | ||
| Microfluidics meet cell biology: bridging the gap by validation and application of microscale techniques for cell biological assays | Q33621842 | ||
| Tuning payload delivery in tumour cylindroids using gold nanoparticles | Q33895572 | ||
| From micro- to nanofabrication with soft materials | Q33926099 | ||
| Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy | Q34354300 | ||
| Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response | Q34375447 | ||
| Reconstruction of cellular signalling networks and analysis of their properties | Q34385115 | ||
| Salivary diagnostics powered by nanotechnologies, proteomics and genomics | Q34506558 | ||
| The role of analytical sciences in medical systems biology | Q34551383 | ||
| Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo | Q34597483 | ||
| Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. | Q34631538 | ||
| Modeling tissue morphogenesis and cancer in 3D. | Q34667330 | ||
| Metabolic fingerprinting as a diagnostic tool. | Q34699756 | ||
| Physics and applications of microfluidics in biology. | Q34739035 | ||
| Poly(dimethylsiloxane) as a material for fabricating microfluidic devices | Q34740741 | ||
| The cancer biomarker problem | Q34767213 | ||
| Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). | Q34777677 | ||
| Optical protein sensor for detecting cancer markers in saliva | Q34778599 | ||
| Disease proteomics | Q35084579 | ||
| Dissecting the metastatic cascade | Q35788115 | ||
| Nanoparticle and targeted systems for cancer therapy | Q35879221 | ||
| Integration from proteins to organs: the IUPS Physiome Project | Q35989877 | ||
| Circulating and disseminated tumor cells | Q36065447 | ||
| Metastasis: recent discoveries and novel treatment strategies | Q36407511 | ||
| Peptide aptamers as guides for small-molecule drug discovery. | Q36437865 | ||
| The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis | Q36537033 | ||
| Cells on chips | Q36548320 | ||
| The war on cancer: a review | Q43666868 | ||
| Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies | Q44918003 | ||
| Surface enhanced Raman scattering of herpes simplex virus in tear film | Q45385425 | ||
| Dynamic single-cell analysis for quantitative biology. | Q45940878 | ||
| Evidence for the existence of hypothetical proteins in human bronchial epithelial, fibroblast, amnion, lymphocyte, mesothelial and kidney cell lines | Q47231190 | ||
| Antibodies cut down to size | Q47275301 | ||
| Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. | Q50728323 | ||
| A new surface plasmon resonance sensor for high-throughput screening applications. | Q51534430 | ||
| Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. | Q53012804 | ||
| Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. | Q54731470 | ||
| Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress | Q59304989 | ||
| Nanotechnology in clinical proteomics | Q60614508 | ||
| Particulate nanomedicines | Q79325586 | ||
| Quantitative measurement of cardiac markers in undiluted serum | Q79555283 | ||
| The long and short of carbon nanotube toxicity | Q81606953 | ||
| Quantitative serum proteomics from surface plasmon resonance imaging | Q81739506 | ||
| Simulated interactions between a Class III antiarrhythmic drug and a figure 8 reentry | Q83048515 | ||
| Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 | ||
| Microfabrication meets microbiology | Q36737169 | ||
| SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics | Q36751400 | ||
| Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles | Q36772567 | ||
| Nanotechnology platforms and physiological challenges for cancer therapeutics | Q36795110 | ||
| Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor | Q36853759 | ||
| Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule | Q36864520 | ||
| Role of nanotechnology in pharmaceutical product development. | Q36905823 | ||
| Towards integrated and sensitive surface plasmon resonance biosensors: a review of recent progress | Q36918423 | ||
| New frontiers in nanotechnology for cancer treatment | Q37055372 | ||
| Integrated microfluidic bioprocessor for single-cell gene expression analysis | Q37068544 | ||
| Clinical toxicities of nanocarrier systems | Q37099798 | ||
| Nanotechnology for breast cancer therapy | Q37229262 | ||
| Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies | Q37321468 | ||
| XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer | Q37580092 | ||
| Review of cell and particle trapping in microfluidic systems | Q37584496 | ||
| Study of antibodies against human melanoma produced by somatic cell hybrids | Q37590914 | ||
| Tumour-initiating cells: challenges and opportunities for anticancer drug discovery | Q37606286 | ||
| Effect of channel geometry on cell adhesion in microfluidic devices | Q39882698 | ||
| Influence of size, surface, cell line, and kinetic properties on the specific binding of A33 antigen-targeted multilayered particles and capsules to colorectal cancer cells. | Q40087438 | ||
| Impact of supervised gene signatures of early hypoxia on patient survival | Q40127249 | ||
| Peptide aptamers in label-free protein detection: 1. Characterization of the immobilized scaffold | Q40247259 | ||
| The hypoxic proteome is influenced by gene-specific changes in mRNA translation | Q40385787 | ||
| Systems biology and new technologies enable predictive and preventative medicine. | Q40473946 | ||
| Drug delivery. Drugs on target | Q43664838 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomedicine | Q261659 |
| nanotechnology | Q11468 | ||
| P304 | page(s) | 640-652 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Current Molecular Medicine | Q5195065 |
| P1476 | title | From nanotechnology to nanomedicine: applications to cancer research | |
| P478 | volume | 10 |
| Q37992185 | A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors |
| Q93184904 | Advances in nanocarriers as drug delivery systems in Chagas disease |
| Q41520311 | Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts |
| Q90027212 | Anticancer, antimicrobial and photocatalytic activities of green synthesized magnesium oxide nanoparticles (MgONPs) using aqueous extract of Sargassum wightii |
| Q37935557 | Berberine hydrochloride: anticancer activity and nanoparticulate delivery system |
| Q60648078 | Bifunctional catechol based linkers for modification of TiO2surfaces |
| Q38725593 | Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery |
| Q104787924 | Biofabrication of ecofriendly copper oxide nanoparticles using Ocimum americanum aqueous leaf extract: analysis of in vitro antibacterial, anticancer, and photocatalytic activities |
| Q98471600 | Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials |
| Q102071961 | Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma |
| Q113871702 | Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches |
| Q38177169 | Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects |
| Q38424722 | Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges |
| Q127295783 | Catalytic degradation of methylene blue by iron nanoparticles synthesized using Galinsoga parviflora, Conyza bonariensis and Bidens pilosa leaf extracts |
| Q30416557 | Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability |
| Q35609201 | Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment. |
| Q28385606 | Cell delivery of therapeutic nanoparticles |
| Q35141565 | Challenges facing sterilization and depyrogenation of nanoparticles: effects on structural stability and biomedical applications |
| Q92127449 | Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs |
| Q52654112 | Controlled release of folic acid through liquid-crystalline folate nanoparticles. |
| Q39608760 | Cytotoxic effects of gold nanoparticles: a multiparametric study |
| Q42380369 | Editorial: Tumor-Derived Extracellular Vesicles: Protocols, Models, and Clinical Evidence |
| Q57167558 | Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy |
| Q26865389 | Engineering artificial machines from designable DNA materials for biomedical applications |
| Q91310852 | Evaluation of anticancer effects of cerium oxide nanoparticles on mouse fibrosarcoma cell line |
| Q51184948 | Exploring the Applicability of Nano-Poration for Remote Control in Smart Drug Delivery Systems. |
| Q128337668 | Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress |
| Q92215951 | Glyco-nanoparticles: New drug delivery systems in cancer therapy |
| Q38951088 | Green synthesis of bacterial gold nanoparticles conjugated to resveratrol as delivery vehicles |
| Q24273349 | Heat shock proteins as danger signals for cancer detection |
| Q38787515 | In Vitro Anticancer Activity of Au, Ag Nanoparticles Synthesized Using Commelina nudiflora L. Aqueous Extract Against HCT-116 Colon Cancer Cells |
| Q38712577 | In vitro evaluation of cytotoxicity, possible alteration of apoptotic regulatory proteins, and antibacterial activity of synthesized copper oxide nanoparticles |
| Q57171272 | In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models |
| Q61447804 | In-situ doped junctionless polysilicon nanowires field effect transistors for low-cost biosensors |
| Q37972138 | Infrared spectroscopy and microscopy in cancer research and diagnosis |
| Q37922723 | Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs |
| Q38011258 | Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery |
| Q26753071 | Microchips and their Significance in Isolation of Circulating Tumor Cells and Monitoring of Cancers |
| Q38077468 | Microfluidics and cancer: are we there yet? |
| Q44860816 | Modelling transport of layered double hydroxide nanoparticles in axons and dendrites of cortical neurons |
| Q96583822 | Multi-nanolayer drug delivery using radiofrequency plasma technology |
| Q51013551 | Nano in cancer: linking chemistry, biology, and clinical applications in vivo. |
| Q104476879 | Nano-Based Theranostic Tools for the Detection and Elimination of Senescent Cells |
| Q38061741 | Nanocarriers for the targeted treatment of ovarian cancers. |
| Q127355407 | Nanoceria: A rare-earth nanoparticle as a promising anti-cancer therapeutic agent in colon cancer |
| Q27318677 | Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer |
| Q65556514 | Nanomedicine Activities in the United States and Worldwide |
| Q52840619 | Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy. |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q86962364 | Nanopotentiated combination cancer therapy: Chemotherapeutic and chemosensitizer (2C approach) |
| Q56425205 | Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world |
| Q126395315 | One-step biological synthesis of cauliflower-like Ag/MgO nanocomposite with antibacterial, anticancer, and catalytic activity towards anthropogenic pollutants |
| Q58046173 | Peptides: minimal drug surrogates to interrogate and interfere with protein function |
| Q38155887 | Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate |
| Q46298250 | ROS-mediated cytotoxic activity of ZnO and CeO2 nanoparticles synthesized using the Rubia cordifolia L. leaf extract on MG-63 human osteosarcoma cell lines |
| Q40967964 | Rapid Biosynthesis of Silver Nanoparticles Using Pepino (Solanum muricatum) Leaf Extract and Their Cytotoxicity on HeLa Cells. |
| Q39089218 | Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma |
| Q93159490 | Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's Disease |
| Q42774007 | Recent advances in nanoparticle formulation of oleanolic acid |
| Q127566452 | Stability and thermal conductivity of CuO nanowire for catalytic applications |
| Q36015388 | Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis |
| Q50719032 | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells. |
| Q89179937 | Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles |
| Q40048909 | Targeting cancer with peptide aptamers. |
| Q36292618 | The nanomedicine revolution: part 1: emerging concepts |
| Q39527453 | The nanomedicine revolution: part 2: current and future clinical applications. |
| Q36401768 | The nanomedicine revolution: part 3: regulatory and safety challenges |
| Q97541823 | The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives |
| Q86405180 | [Nanomedicine in cancer treatment--small particles brings hope] |
Search more.